biomarkers

Related by string. Biomarkers * * identify protein biomarkers . established biomarkers Transthyretin . validate biomarkers . predictive biomarkers . Cancer Epidemiology Biomarkers . protein biomarkers . Pacific Biomarkers . molecular biomarkers . diagnostic biomarkers . Banyan Biomarkers . inflammatory biomarkers . cardiac biomarkers . Cancer Biomarkers . genetic biomarkers *

Related by context. All words. (Click for frequent words.) 87 biomarker 77 protein biomarkers 72 molecular biomarkers 69 genetic biomarkers 68 diagnostic biomarkers 68 prognostic markers 68 genetic markers 67 molecular markers 67 microRNA biomarkers 66 predictive biomarkers 66 biomarker discovery 66 molecular biomarker 65 diagnostic biomarker 65 gene expression profiling 65 genomic 65 protein biomarker 65 tumor hypoxia 64 companion diagnostics 64 biomarker identification 64 genetic variants 64 genetic polymorphisms 64 Biomarkers 64 microRNAs 64 validate biomarkers 64 miRNA biomarkers 63 prognostic marker 63 miRNAs 63 biomarker assays 63 therapeutics 63 metabolomics 63 gene expression 63 miRNA 63 clusterin 63 microRNA 63 biologic pathways 62 serum biomarkers 62 vivo 62 genomic biomarkers 62 Biomarker 62 somatic mutations 62 predictive biomarker 62 methylation markers 62 kinase inhibitors 62 biochemical markers 62 miRNA expression 62 small molecule inhibitors 62 toxicogenomics 62 genetic variants associated 62 biomarker assay 61 pharmacogenetic 61 susceptibility genes 61 metabolomic 61 DNA methylation biomarkers 61 NGAL 61 prognostic biomarkers 61 pharmacogenetic tests 61 diagnostic prognostic 61 eTag assays 61 galectin 3 61 HAAH 61 genomewide 61 proteomic 61 prognostic 61 genetic variations 61 genomic alterations 61 metabolomic profiling 61 KineMarker TM 61 risk stratification 60 pharmacogenetic test 60 DNA methylation markers 60 diagnostic assays 60 gene variants 60 biological pathways 60 gene fusions 60 methylated DNA 60 proteins 60 molecular assays 60 inflammatory biomarkers 60 gene amplification 60 biochemical marker 60 GPCR targets 60 quantitative proteomics 60 biosensors 60 splice variants 60 KRAS mutation 60 immunochemical 60 microarray 60 noninvasive imaging 60 gene expression profiles 60 SiMoA 60 CCR3 60 genomic proteomic 60 HIF PH inhibitors 60 SNPs 60 genetic determinants 60 breast cancer metastasis 60 PET imaging 60 cellular pathways 60 PITX2 59 ADME properties 59 TLR9 agonists 59 methylation patterns 59 neutrophil gelatinase associated lipocalin 59 Clusterin 59 molecular profiling 59 tumor subtypes 59 FDG PET 59 splice variant 59 serum protein biomarkers 59 monoclonal antibodies 59 kinase assays 59 DNA methylation patterns 59 peptides 59 ALK inhibitors 59 causative genes 59 NSCLC tumors 59 cerebrospinal fluid CSF 59 ADME Tox 59 gene polymorphisms 59 DNA methylation biomarker 59 preclinically 59 kinase profiling 59 microRNA expression 59 polymorphisms 59 micro RNA 59 metabolic profiling 59 multiplex assay 59 transcriptomics 59 CDK inhibitors 59 P#X# 58 proteomics 58 Corus CAD 58 stratifying patients 58 MetaChip 58 lipid 58 transcriptomic 58 Epigenomics proprietary 58 single nucleotide polymorphism 58 miRNA molecules 58 vitro assay 58 druggable targets 58 gene expression patterns 58 Molecular imaging 58 putative biomarkers 58 multi analyte 58 bioluminescent imaging 58 prognostic indicators 58 molecular diagnostic tests 58 surrogate markers 58 peptide BNP 58 endophenotypes 58 PARP inhibitors 58 Tr DNA 58 microarrays 58 PI3K inhibitors 58 Lp PLA2 58 differentially expressed proteins 58 noncoding RNAs 58 molecular 58 Mammostrat 58 clinically validated 58 Phylomer ® 58 PCA3 gene 58 multiplexed assays 58 molecular underpinnings 58 susceptibility loci 58 A3 adenosine receptor 58 molecules 58 stratify patients 58 IGF 1R 58 therapies 58 histone modifications 58 BioMAP 58 validating biomarkers 58 microRNA profiling 58 radiotracers 58 diagnose Alzheimer disease 58 PIK3CA 58 small molecule activators 58 chemoprevention 58 cell signaling pathways 58 therapeutic monoclonal antibody 58 cardiac troponin T 58 cancer therapeutics 58 biomolecular interactions 58 biomarker validation 58 neurodegenerative diseases 57 MSMB 57 Her2/neu 57 antibody 57 mTOR inhibitors 57 immunohistochemical 57 breast cancer subtypes 57 Septin9 57 underlying molecular mechanisms 57 molecular imaging 57 personalized medicine 57 MAbs 57 sarcosine 57 aptamers 57 metabolite identification 57 tumor biopsies 57 cystatin C 57 NPRL2 57 molecular abnormalities 57 B7 H3 57 IGF IR 57 HER3 57 phenotypes 57 RECAF 57 Anticalins ® 57 genotyping 57 Trofex 57 vimentin 57 membrane proteins 57 immunotherapeutic approaches 57 MicroRNA 57 sphingolipids 57 JAK3 57 atherosclerosis regression 57 pharmacogenetics 57 anti angiogenic drugs 57 mass spectrometry 57 molecular subtypes 57 Therapeutic antibodies 57 signaling pathways 57 molecular determinants 57 antiangiogenic agents 57 NuroPro ® 57 prognostic indicator 57 multigene 57 HDAC inhibitors 57 aCGH 57 TLE3 57 chemosensitivity 57 genomic markers 57 small molecule 57 oxysterols 57 microRNA miRNA 57 Lp PLA 2 57 VEGF receptor 57 novel peptide 57 array CGH 57 endoglin 57 molecular diagnostic 57 myelofibrosis polycythemia vera 57 LungExpress Dx 57 DNA microarrays 57 investigational therapies 57 OnDose TM 57 GPCRs 57 DNA methyltransferases 57 antiplatelet therapies 57 positron emission tomography PET 57 HERmark 57 isotypes 57 autoantibodies 57 tandem mass spectrometry 57 perfusion CT 57 genetic loci 57 multiplex assays 57 siRNA therapeutics 57 biomolecules 57 pharmacogenomic tests 57 molecular pathways 57 antithrombotic agents 57 toxicogenomic 57 pharmacologic intervention 57 bioinformatic approaches 56 myeloproliferative disorders 56 EGFR mutations 56 biochips 56 gene expression assays 56 Nanobodies 56 genetic aberrations 56 genomic biomarker 56 disease modifying 56 rxRNA compounds 56 proton MR spectroscopy 56 therapeutic monoclonal antibodies 56 S#A# [002] 56 PARP inhibition 56 metabolic enzymes 56 KineMed 56 HERmark assay 56 gene expression biomarkers 56 hypermethylated 56 molecularly targeted 56 VKORC1 56 Hedgehog inhibitor 56 Hsp# inhibition 56 Microarrays 56 HER2 overexpression 56 presymptomatic 56 potent inhibitors 56 DNA microarray 56 Nanobodies ® 56 microarray experiments 56 molecular diagnostic assay 56 GPCR 56 situ hybridisation 56 WT1 56 SERMs 56 molecularly targeted therapies 56 pharmacogenetic testing 56 autism susceptibility genes 56 ion channels 56 ChemoFx ® 56 RNA sequences 56 virulence genes 56 pharmacodynamic biomarkers 56 GAP #B# 56 optical biosensors 56 GSTP1 56 proteomic analysis 56 transgenic mouse models 56 skin sterol 56 microdeletions 56 BRAF mutation 56 #F FDG PET 56 quantitate 56 CellPort Technologies 56 epigenetic mechanisms 56 p#INK#a 56 Genetic variants 56 quantitative PCR qPCR 56 prognostic biomarker 56 kinase inhibition 56 susceptibility gene 56 Mass spectrometry 56 pharmacodynamic markers 56 OGG1 56 HDACs 56 EGFR inhibition 56 hERG 56 telomerase activation 56 epigenetic markers 56 ALN TTR 56 EGFR HER 56 vivo potency 56 metabonomics 56 tumor suppressor protein 56 theranostic 56 peptide 56 analytes 56 nutrigenomic 56 peptide antigens 56 SNP genotyping 56 anticancer therapeutics 56 PKCi 56 engineered RAP peptides 56 Flow cytometry 56 quantitative PCR 56 CyPath ® assay 56 synthetic peptides 56 FISH fluorescence 56 OMP #M# 56 causal variants 56 antisense oligonucleotides 56 prostate cancer CaP 56 MAPK pathway 56 TLR8 56 differentially expressed genes 56 antisense drugs 56 antibodies 56 RECAF TM 56 intracellular pathways 56 anti CD# antibodies 56 Smurf1 56 ELISpot 56 tumor antigens 56 VEGF inhibitors 56 stem cell therapeutics 56 fluorescent probes 56 pharmacologic 56 renin inhibitors 56 oligonucleotide arrays 56 splice junctions 55 secreted proteins 55 genomewide association studies 55 Septin 9 55 multitargeted 55 transcriptomes 55 micro RNAs 55 bioactive compounds 55 mechanistic insights 55 Azedra 55 pharmacological approaches 55 bioassays 55 predictive toxicology 55 COLD PCR 55 MammaPrint R 55 biosensing 55 comparative genomic hybridization 55 MAPCs 55 throughput RNAi 55 diagnostic tests 55 chemopreventive agent 55 gene mutations 55 diagnostic 55 autoantibody 55 qRT PCR 55 neuronal nicotinic receptors NNRs 55 resolvins 55 ubiquitin ligases 55 STK# [002] 55 PET tracers 55 anti JCV antibodies 55 quantitative gene expression 55 Velculescu 55 imaging modality 55 PGDH 55 carcinoembryonic antigen 55 liver fibrosis 55 immunoregulatory 55 K ras 55 chromosomal regions 55 siRNA compounds 55 Affymetrix microarray technology 55 protein biomarker discovery 55 salivary diagnostics 55 surface plasmon resonance SPR 55 antiviral therapies 55 FGFR3 55 metabolic parameters 55 p# INK4a 55 PluriCells TM 55 chemopreventive 55 metabolite profiling 55 miRNA profiling 55 Prognostic 55 epithelial tumors 55 tubulin inhibitor 55 protein misfolding 55 MMP inhibitors 55 immunohistochemical staining 55 miRview mets 55 PLAC test 55 protein albumin 55 metabolites 55 DNA methylation 55 p# activation 55 lincRNAs 55 olaparib 55 biopsied tissue 55 immunological diseases 55 PSP# [002] 55 immunoregulation 55 ncRNA 55 cardiac troponin 55 prostate cancer PCa 55 mAbs 55 dAbs 55 magnetic resonance spectroscopy MRS 55 VeraTag assays 55 anti CD3 55 Cystatin C 55 SELDI 55 Quanterix 55 malignant nodules 55 Array CGH 55 loci 55 miRNA genes 55 PD2i ® 55 druggable target 55 small molecule agonists 55 gefitinib Iressa 55 ptau 55 Affibody ® molecules 55 nanoprobes 55 glycan 55 RNA seq 55 chromosome aberrations 55 lipid metabolites 55 proteomes 55 molecular mechanisms 55 pathogenic mechanisms 55 NT proBNP 55 Cardiotoxicity 55 kinases 55 RNAi therapeutic targeting 55 multiplex PCR 55 prognostic significance 55 FLT3 55 ANGPTL4 55 histone deacetylase inhibitors 55 CCR1 55 β amyloid 55 anti fibrotic 55 A2 Lp PLA2 55 LungExpress Dx TM 55 MEK inhibitors 55 cMET 55 Li Fraumeni 55 nanomolar 55 signaling cascades 55 neuro imaging 55 MIF protein 55 Circulating Tumor Cells 55 biochip 55 drug metabolizing enzymes 55 subclinical atherosclerosis 55 AlloMap testing 55 miR #b [002] 55 EpCAM 55 SNP arrays 55 aggregated Abeta 55 exome sequencing 55 preclinical 55 nonclinical studies 55 identify protein biomarkers 55 selective inhibitors 55 CellCiphr 55 RT qPCR 55 optimal dosing regimens 55 GRP# 55 PKM2 55 serine protease 55 soluble CD# ligand 55 molecular diagnostic assays 55 TNFa 55 iPSC 55 PI3K AKT 55 biologic therapeutics 55 molecular pathway 55 protein microarrays 55 glycomics 55 Protein Kinase C 55 gene expression microarrays 54 Proteomic 54 methylation biomarkers 54 Darapladib 54 KinomeScan 54 methylation 54 antibody therapeutics 54 Micro RNAs 54 Oncotype 54 mechanistic insight 54 Biomerk Tumorgrafts 54 transcriptional regulation 54 protein misfolding diseases 54 pathophysiological mechanisms 54 sCJD 54 proteomic biomarkers 54 SPINK1 54 ProteinChip 54 Epidermal Growth Factor Receptor 54 xCELLigence System 54 MAbs targeting 54 non coding RNA 54 rxRNA 54 Locked Nucleic Acid LNA 54 vitro assays 54 biochemical mechanisms 54 PTEN gene 54 therapeutically relevant 54 biochemical assays 54 beta1 integrin 54 BioMAP ® 54 JAK2 inhibitor 54 FDG PET scans 54 gene loci 54 whole genome genotyping 54 plasma kallikrein 54 ChIP Seq 54 phenotyping 54 5 hydroxymethylcytosine 54 natriuretic peptide 54 proteasome inhibitors 54 antiangiogenic drugs 54 kidney urologic 54 genotypic 54 FDDNP 54 NMP# 54 p tau 54 humanized monoclonal antibodies 54 perfusion imaging 54 RRM1 54 G Protein Coupled 54 cells CTCs 54 K ras mutations 54 metabolomic profiles 54 Genetic variations 54 ChIP chip 54 JAK2 inhibitors 54 mitochondrial toxicity 54 protein kinases 54 thyroid stimulating hormone 54 HG PIN 54 therapeutic proteins 54 causative gene 54 NPM1 54 IFRD1 54 clinically relevant 54 inhibit enzymes 54 ETBs 54 histone deacetylase HDAC 54 novel peptides 54 ELISA assays 54 antibody arrays 54 MGd 54 sDNA 54 ncRNAs 54 antitumour 54 miR #a [002] 54 pharmacogenomic 54 lipid abnormalities 54 cell lysate 54 mesothelin 54 NPM1 mutation 54 Mechanistic studies 54 Reverse Cholesterol Transport 54 antagomirs 54 platelet function 54 IDH1 54 situ hybridization 54 sirtuin enzymes 54 molecular mechanisms underlying 54 receptor subtypes 54 AtherOx 54 anticancer drugs 54 HER2 expression 54 promoter methylation 54 germline mutations 54 Proteomics 54 sPLA2 54 IgM antibody 54 Onconase 54 pre malignant lesions 54 chromosomal mutations 54 Rosetta Genomics microRNA 54 PROLARIS 54 histone deacetylases 54 chemopreventive agents 54 Nanobody 54 protein isoforms 54 neuroprotection 54 genomic profiling 54 DCE MRI 54 microarray analysis 54 Theranostics 54 chemotherapeutic agents 54 Getzenberg 54 fluorescence imaging 54 chemotherapeutics 54 selective inhibition 54 biodistribution 54 PCA3 54 HDAC inhibition 54 exosome 54 pharmacodynamic PD 54 bacterial genomes 54 glycoproteins 54 lipids 54 SELDI TOF 54 romazarit 54 peptide ligands 54 diagnostic modality 54 glycan structures 54 Sanger sequencing 54 Syk 54 genes CYP#C# 54 SIRT1 gene 54 sigma receptors 54 therapeutic antibodies 54 CYT# potent vascular disrupting 54 Wnt signaling pathway 54 Wnt#b 54 PICALM 54 CPE delta N 54 KRAS mutation status 54 CSF biomarkers 54 Stapled Peptide 54 humanised antibody 54 inhibit viral replication 54 pathophysiological 54 genomics proteomics 54 PlGF 54 IgG antibodies 54 florbetaben 54 flavopiridol 54 urine dipstick 54 pro angiogenic 54 ImmuKnow 54 reagent kits 54 PPARγ 54 intracellular signaling pathways 54 immunotoxins 54 autoimmune diseases 54 VeriStrat 54 UsiRNAs 54 transient elastography 54 immunohistochemistry IHC 54 epigenetic regulation 54 silico 54 nonviral 54 N glycan 54 ALK mutations 54 Membrane proteins 54 enterotypes 54 Smac mimetics 54 C. pneumoniae 54 albuminuria 54 gene locus 54 TPMT 54 preclinical efficacy 54 serum markers 54 p# biomarker 54 HLA antibody 54 PITX2 methylation 54 HER2 gene 54 HER1 54 autoantigen 54 PDGF receptor 54 cardiac biomarkers 54 Spiegelmers 54 activating mutation 54 hypoxic tumors 54 M2 subunit 54 Fibroblast Growth Factor Receptor 54 molecular pathology 54 therapeutic radiopharmaceuticals 53 Chronix 53 Anticalins R 53 peptide therapeutics 53 mTOR inhibition 53 induced sputum 53 Cyclin E 53 QPCR 53 tumor microenvironment 53 prostate carcinoma 53 ion channel 53 genes 53 myeloperoxidase 53 circadian genes 53 molecularly targeted therapy 53 metabolite profiles 53 chromosomal rearrangement 53 multicenter trials 53 sortilin 53 immunomodulation 53 platelet activation 53 epigenetic therapeutics 53 posttranslational modifications 53 Aurora kinase 53 proteome 53 Pseudomonas aeruginosa infections 53 D Dimer 53 targeted radiotherapeutic 53 S. maltophilia 53 vascular disrupting agents 53 multimodality imaging 53 phosphorylated proteins 53 gastric carcinoma 53 microRNA sequences 53 pharmacodynamic parameters 53 EGF receptors 53 AclarusDx ™ 53 cytotoxicity assays 53 Exelixis compounds 53 Panzem 53 ResponseDX 53 autoantigens 53 EGFR tyrosine kinase inhibitors 53 miRview TM mets 53 mGluR2 NAM 53 insulin analogs 53 mimetics 53 KRAS mutations 53 HepDirect prodrug 53 PI3K 53 oligonucleotide therapeutics 53 ZNF# 53 quantitative trait loci 53 OTCBB PWRM.OB 53 transmembrane proteins 53 PGx 53 miRview ™ squamous 53 biodegradable nanoparticles 53 ESBA# 53 molecular signaling pathways 53 cDNA microarray 53 biological molecules 53 precursor lesions 53 Curaxin 53 adiponectin 53 urine NGAL 53 massively parallel sequencing 53 anticancer agents 53 5 hmC 53 p# inhibitor 53 HIF 1α 53 oral gallium 53 metastatic lymph nodes 53 therapeutic peptide 53 ligands 53 primate genomes 53 potently inhibit 53 protein kinase C 53 primary cilia 53 microRNA molecules 53 nomograms 53 aberrant methylation 53 Wnts 53 KRAS oncogene 53 Septin9 biomarker 53 mutational analysis 53 Hedgehog pathway 53 AttoSense 53 neuroinflammation 53 SELDI TOF MS 53 PI3K/mTOR 53 computational methods 53 Stat5 53 Squalamine 53 nutrigenomics 53 tolerability pharmacokinetics 53 neuro degenerative diseases 53 immunoassays 53 ErbB3 53 KRAS variant 53 Prostate Px + 53 TMEM#B 53 antiviral compounds 53 kallikrein 53 synthetic lethality 53 PGxPredict tests 53 troponin T 53 rBChE 53 inhibit metastasis 53 Immunoassays 53 shRNA libraries 53 etiologic 53 oncolytic viruses 53 gastric carcinomas 53 microarray gene expression 53 monoclonal 53 BioMAP ® Systems 53 pharmacological chaperone 53 Brd4 53 pharmacological 53 comparative genomic hybridization CGH 53 anticancer compounds 53 Dr. Rafii 53 transcriptome 53 anti angiogenic agents 53 pharmacodynamic 53 tumor histology 53 hematopoietic cell 53 FGFR1 53 physiologic mechanisms 53 ArQule Kinase Inhibitor Platform 53 mtDNA mutations 53 histone acetylation 53 ADME 53 murine models 53 LRRK2 gene 53 hypermethylation 53 APTIMA HPV 53 molecular diagnostics 53 #F FDG 53 epigenomic 53 multiplex ligation dependent 53 beta secretase inhibitors 53 hedgehog pathway 53 transgenic mouse model 53 NNR Therapeutics 53 Luminex xMAP technology 53 osteopontin 53 ColoMarker 53 oncogenesis 53 TGF beta pathway 53 genomic sequencing 53 antisense inhibitors 53 alkaline phosphatase ALP 53 NMR LipoProfile test 53 genomic loci 53 Zolinza 53 EGFR 53 genomics 53 receptor antagonists 53 metabolic disorders 53 cathepsin K 53 sphingolipid 53 subtypes 53 pDCs 53 genomic variation 53 beta catenin 53 HLA DRB1 53 proteomics genomics 53 Metabolomics 53 theranostics 53 Dr. Pasinetti 53 DNA Methylation 53 cerebrospinal fluid biomarkers 53 pharmacodynamic effects 53 miR #a [001] 53 immunofluorescent 53 VeraTag 53 lipoprotein metabolism 53 D 1mT 53 antigen PSA 53 epigenetic therapies 53 mass spectroscopy 53 mimetic compounds 53 aptamer therapeutics 53 tissue microarrays 53 Cytochrome P# 53 binding affinities 53 PCR assay 53 dysbindin 53 promoter hypermethylation 53 underlying pathophysiology 53 Abeta# 53 PI3 kinase inhibitors 53 genomic microarray 53 MetAP2 53 EGFR mutation status 53 NuroPro R 53 RBP4 53 HOXB# 53 Whole Genome 53 siRNA therapeutic 53 Haptoglobin 53 perilipin 53 endothelin antagonists 53 cancer immunotherapies 53 microbiomes 53 eIF 4E 53 histone deacetylase HDAC inhibitors 53 protein 53 noninvasive diagnostic 53 TLR antagonists 53 CTLA4 Ig 53 TGFBR1 * 6A 53 surrogate marker 53 gene rearrangements 53 microRNA therapeutics 53 HER2 HER3 53 KRAS status 53 neuroprotective properties 53 GRNCM1 53 prostanoid 53 modifier genes 53 phenotypic 53 IGFBP2 53 proteomic technologies 53 reverse vaccinology 53 SNP Array #.# 53 tumorigenicity 53 HER2 53 JAK2 53 prognostically 53 neuroprotective 53 methyltransferases 53 BRAF mutations 53 missense mutations 53 small molecule modulators 53 biochemical abnormalities 53 molecular beacons 53 diabetic kidney 53 nestin 53 polycythemia vera PV 53 ERCC1 53 stem cell differentiation 53 precancerous stem cells 53 sirtuin therapeutics 53 lipid metabolism 53 quantitative RT PCR 53 PPAR γ 53 colorectal carcinogenesis 53 preclinical models 53 HLA molecules 53 mAb 53 genetic underpinnings 53 antitumoral 53 C1q 53 immune modulating 53 therapeutic antibody 53 microRNAs miRNAs 53 chromatin immunoprecipitation 53 OXIGON TM 53 haematopoietic 53 tissue fibrosis 53 antiangiogenic therapy 53 lymphatic mapping 53 iPS derived 53 AT1R 53 inactivating mutations 53 enzyme inhibitors 53 Neurodegenerative diseases 53 hsCRP 53 amyloid imaging 53 protein tyrosine phosphatase 53 CEACAM1 53 Syllego system 53 vorinostat 53 c MYC 53 endostatin

Back to home page